dronabinol has been researched along with indazoles in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Borea, PA; Canazza, I; De Luca, MA; Di Rosa, F; Fantinati, A; Gregori, A; Margiani, G; Marti, M; Ossato, A; Rimondo, C; Serpelloni, G; Trapella, C; Varani, K; Vincenzi, F | 1 |
| Marusich, JA; Thomas, BF; Wiley, JL | 1 |
| Fantegrossi, WE; Tai, S | 1 |
| Banister, SD; Kassiou, M; Kevin, RC; McGregor, IS; Mitchell, AJ; Moir, M; Stuart, J; Wood, KE | 1 |
| Bader, M; Cohen, E; Gabet, Y; Katz, Y; Lenchinski, T; Meningher, I; Pick, CG; Rotenberg, M; Rubovitch, V; Schreiber, S; Wolf, EU | 1 |
| Banister, SD; Bladen, C; Connor, M; Kassiou, M; Sachdev, S; Santiago, M | 1 |
| Kinsey, SG; Poklis, JL; Trexler, KR; Vanegas, SO | 1 |
| Forster, MJ; Gatch, MB; Shetty, RA; Tourigny, A | 1 |
| Cabanlong, CV; Fantegrossi, WE; Prather, PL; Russell, LN | 1 |
2 review(s) available for dronabinol and indazoles
| Article | Year |
|---|---|
Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids.
Topics: Animals; Body Temperature Regulation; Brain; Cannabinoids; Designer Drugs; Dronabinol; Humans; Indazoles; Indoles; Locomotion; Naphthalenes; Nociception; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Valine | 2017 |
Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.
Topics: Adamantane; Animals; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoids; Cytochrome P-450 Enzyme System; Dronabinol; Drug Interactions; Humans; Indazoles; Indoles; Morpholines; Naphthalenes; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2017 |
7 other study(ies) available for dronabinol and indazoles
| Article | Year |
|---|---|
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
Topics: Adamantane; Aggression; Animals; Behavior, Animal; Binding, Competitive; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabis; Catalepsy; Dopamine; Dronabinol; Humans; In Vitro Techniques; Indazoles; Indoles; Male; Mice; Motor Activity; Naphthalenes; Nucleus Accumbens; Pain Threshold; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reflex, Abnormal; Seizures | 2016 |
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoids; Dronabinol; Endocannabinoids; Illicit Drugs; Indazoles; Locomotion; Male; Memory Disorders; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Valine | 2017 |
Functional effects of synthetic cannabinoids versus Δ
Topics: Animals; Anxiety; Body Temperature; Depression; Dronabinol; Indazoles; Male; Maze Learning; Memory; Mice, Inbred ICR; Motor Activity; Nociception; Psychotropic Drugs; Sensory Thresholds; Valine | 2019 |
Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists.
Topics: Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoids; Cyclic AMP; Dronabinol; GTP-Binding Proteins; HEK293 Cells; Humans; Indazoles; Indoles; Morpholines; Naphthalenes; Quinolines; Receptor, Cannabinoid, CB1 | 2020 |
The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice.
Topics: Animals; Cannabinoids; Dronabinol; Drug Tolerance; Indazoles; Locomotion; Male; Mice; Mice, Inbred C57BL; Receptor, Cannabinoid, CB1; Rimonabant; Substance-Related Disorders; Tandem Mass Spectrometry | 2020 |
Behavioral pharmacology of five novel synthetic cannabinoids.
Topics: Animals; Cannabinoids; Dronabinol; Indazoles; Locomotion; Male; Mice; Rats; Rats, Sprague-Dawley | 2022 |
Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors.
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoids; Dronabinol; Indazoles; Mice; Receptor, Cannabinoid, CB1 | 2022 |